J9062 HCPCS Level II code: Injection, amivantamab 5 mg and hyaluronidase-lpuj
J9062 is the HCPCS code for “Injection, amivantamab 5 mg and hyaluronidase-lpuj” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9062Injection, amivantamab 5 mg and hyaluronidase-lpuj
Short description: Inj amivantamab 5mg hyaluron
HCPCS · United States
Medicare details
The indicators CMS publishes with J9062 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care
- BETOS category
- Chemotherapy
- Added
- Jul 1, 2026
Where J9062 sits
- 1J codesDrugs administered other than orally
- 2Active code J9062Injection, amivantamab 5 mg and hyaluronidase-lpuj
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9062 mean?
J9062 is the HCPCS code for “Injection, amivantamab 5 mg and hyaluronidase-lpuj” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9062?
CMS lists J9062’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9062
All J codesJ9056Injection, bendamustine hydrochloride (vivimusta), 1 mgJ9057Injection, copanlisib, 1 mgJ9058Injection, bendamustine hydrochloride (apotex), 1 mgJ9059Injection, bendamustine hydrochloride (baxter), 1 mgJ9060Injection, cisplatin, powder or solution, 10 mgJ9061Injection, amivantamab-vmjw, 2 mgJ9063Injection, mirvetuximab soravtansine-gynx, 1 mgJ9064Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mgJ9065Injection, cladribine, per 1 mgJ9066Injection, bendamustine hydrochloride (avyxa), 1 mgJ9070Cyclophosphamide, 100 mgJ9071Injection, cyclophosphamide (auromedics), 5 mg